Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of
dementia in older individuals (aged≥ 65 years). To gain a deeper understanding of the …

Background. Alzheimer's disease (AD) is a progressive neurodegenerative disorder
affecting many individuals worldwide with no effective treatment to date. AD is characterized …

Alzheimer's disease is an irreversible, progressive brain disorder that accounts for about 50–
75% of all cases of dementia. 1 Alzheimer's disease is characterised by the presence of …

Importance For informed decision making on diagnosis and treatment of dementia,
physicians and their patients rely on the generalizability of evidence from published studies …

Abstract Background and Objectives: Recently, longitudinal studies of Alzheimer's disease
have gathered a substantial amount of neuroimaging data. New methods are needed to …

Alzheimer's disease (AD) is one of the most common neurodegenerative illnesses
displaying the highest death rate in the elderly. However, the existing AD diagnostic system …

The need for preventive therapies that interrupt the progression of Alzheimer's disease (AD)
before the onset of symptoms or when symptoms are emerging is urgent and has spurred …

Background: Although primarily a neurodegenerative process, there is increasing
awareness of peripheral disease mechanisms in Parkinson's disease. To investigate …

Background For the recruitment and monitoring of subjects for therapy studies, it is important
to predict whether mild cognitive impaired (MCI) subjects will prospectively develop …

The early prediction of Alzheimer's disease (AD) can be vital for the endurance of patients
and establishes as an accommodating and facilitative factor for specialists. The proposed …